Bicycle Therapeutics plc: Bicycle Therapeutics to Participat

Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced

Related Keywords

New York , United States , United Kingdom , Cambridge , Cambridgeshire , Sarah Sutton , David Borah , Nasdaq , Capital Markets Corporate Communications , Bicycle Therapeutics , Jefferies Healthcare Conference , Investors Media , Bicycle Toxin Conjugate , Cancer Research United Kingdom Centre , Bicycle , Herapeutics , Articipate , Efferies , Healthcare , Conference ,